fbpx

Day

June 8, 2015
Expands focus on gram-negative bacteria by adding Potentiator program to pipeline of novel antibiotic compounds.CAMBRIDGE, Mass.- June 8, 2015 -  Spero Therapeutics, LLC, a biopharmaceutical company founded to develop novel therapies for the treatment of bacterial infections, announced that the company secured $30M million in a Series A financing.  Lundbeckfond Ventures led the round as a...

News

90 million to 18 Talented Researchers
19. October 2020
Søren Dinesen Lumdbeckfonden
Psychiatry research leads to prestigious science prize
13. October 2020
Christian Sandøe Musaeus Lundbeckfonden
Concentrating on Dementia
13. October 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge